June 30 (Reuters) - Amgen (AMGN.O), opens new tab said on Monday its experimental cancer therapy, when combined with chemotherapy, met the main goal in a late-stage trial.

Amgen is seeking its next blockbuster medicine ... The medicine led to an average weight loss of about 20% after 52 weeks, with no plateau observed. And importantly, MariTide is administered once a ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs containing GLP-1, a hormone that slows digestion and helps with sustained ...